Learn about the workflow and basic feature of our software with our quick overview video.
Learn about the different options CytoSure Interpret offers for processing your aCGH data.
Learn about the most popular features offered by CytoSure Interpret for the import and interpretation of your data.
A guide to the new target regions feature available in CytoSure Interpret Software version 4.10 onwards, allowing the user to focus their analysis on specific regions of interest in the data.
Learn about the options CytoSure Interpret provides for automating, uploading and processing sample ID information to the database.
Learn about the automatic CNV classification feature in CytoSure Interpret. The video covers the set up and customisation of classifier sets, how they can aid the interpretation process and provide a faster, more standardised analytical workflow.
Learn about the wide range of user-defined probe filtering options in CytoSure Interpret. The video explores the various probe filter parameters available, how to apply them and how they can be used to refine data analysis.
Learn more about the new annotation track update feature in CytoSure Interpret version 4.11. The video details how to check for annotation track updates and access the very latest versions.
Learn how to track the progress of a case in the Case Status field. The video details the various stages, transitioning between them and how the function can be used to search for samples in database management.
Learn how to customise CNV detection protocols. The video focuses on the setting up of mosaic CNV analysis protocols and the selection of appropriate threshold factors for the accurate detection of mosaic gains and losses.
Dr. Stephen Moore will share his experience utilising OGT's CytoSure® chromosomal microarrays in various tumour types. Specifically, he will highlight the different applications of the single nucleotide polymorphism (SNP) track beyond oligonucleotides confirmation.
Lora Bean provides valuable insights into the use of microarrays and NGS in parallel for CNV detection. While CNV calls from NGS data are becoming increasingly popular, they must be confirmed due to the significant false positive rate associated with them.
Dom McMullan discusses the implementation of the CytoSure® Constitutional v3 microarray in the NHS laboratory, and how it facilitated cost-effective, evidence-based analysis of large populations.
Kris Van Den Bogaert discusses the evaluation of the CytoSure® Constitutional v3 microarrays in prenatal and postnatal research.
Madhuri Hegde expands on her work with OGT combining NGS, microarrays — including OGT’s CytoSure® Disease-Focused Research arrays — and an all-inclusive genomic data interpretation platform for comprehensive analysis of genetic disorders.
Dr Tracey Lewis delve into the benefits of combining the study of copy number variations (CNVs) and single nucleotide variations (SNVs) for enhanced mutation detection across a range of genetic conditions.